| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 729040 | 85304 | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85304/85304_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85304/85304_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2020-07-29 | 1 | 1 | 1 | 2020-07-30 | 2020-07-29 | 0 | 2020-11-06 | View Edit Delete | ||||||||||||
| 729034 | 85301 | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 28 comprimidos | 160 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85301/85301_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85301/85301_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2020-07-29 | 1 | 1 | 1 | 2020-07-30 | 2020-07-29 | 0 | 2020-11-06 | View Edit Delete | ||||||||||||
| 758548 | 85300 | VOLTADOL 140 MG APOSITO ADHESIVO MEDICAMENTOSO | VOLTADOL 140 MG APOSITO ADHESIVO MEDICAMENTOSO, 5 apósitos | 140 mg | 35 | 5 | 69 | 5 apósitos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85300/85300_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85300/85300_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43807 | HALEON SPAIN S.A. | 2020-07-29 | 1 | 1 | 1 | 2020-07-30 | 2022-09-30 | 1 | 2023-03-24 | View Edit Delete | ||||||||||||
| 764108 | 85300 | VOLTADOL 140 MG APOSITO ADHESIVO MEDICAMENTOSO | VOLTADOL 140 MG APOSITO ADHESIVO MEDICAMENTOSO, 10 apósitos | 140 mg | 35 | 10 | 69 | 10 apósitos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85300/85300_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85300/85300_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43807 | HALEON SPAIN S.A. | 2020-07-29 | 1 | 1 | 1 | 2020-07-30 | 2024-01-19 | 1 | 2024-06-19 | View Edit Delete | ||||||||||||
| 729032 | 85299 | FINGOLIMOD VIATRIS PHARMACEUTICALS 0,5 MG CAPSULAS DURAS EFG | FINGOLIMOD VIATRIS PHARMACEUTICALS 0,5 MG CAPSULAS DURAS EFG, 28 capsulas | 0,5 mg | 5 | 28 | 43 | 28 capsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85299/85299_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85299/85299_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44524 | VIATRIS PHARMACEUTICALS S.L. | 2020-07-29 | 1 | 1 | 1 | 2020-07-30 | 2020-07-29 | 0 | 2026-02-11 | View Edit Delete | ||||||||||||
| 729030 | 85298 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA NORMON 40 MG/5 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA NORMON 40 MG/5 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85298/85298_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85298/85298_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2020-11-12 | View Edit Delete | ||||||||||||
| 729029 | 85297 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA NORMON 40 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA NORMON 40 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85297/85297_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85297/85297_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2020-11-12 | View Edit Delete | ||||||||||||
| 729028 | 85296 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA NORMON 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA NORMON 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85296/85296_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85296/85296_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2020-11-12 | View Edit Delete | ||||||||||||
| 729027 | 85295 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA NORMON 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA NORMON 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85295/85295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85295/85295_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2020-11-12 | View Edit Delete | ||||||||||||
| 729026 | 85294 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA NORMON 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA NORMON 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85294/85294_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85294/85294_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2020-11-12 | View Edit Delete | ||||||||||||
| 729025 | 85293 | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85293/85293_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85293/85293_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2020-11-06 | View Edit Delete | ||||||||||||
| 729024 | 85292 | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 10 MG/320 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 10 MG/320 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 320 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85292/85292_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85292/85292_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2020-11-06 | View Edit Delete | ||||||||||||
| 729023 | 85291 | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA PENSA 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85291/85291_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85291/85291_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 0 | 2020-11-06 | View Edit Delete | ||||||||||||
| 729019 | 85289 | DASATINIB STADA 70 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DASATINIB STADA 70 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 70 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85289/85289_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85289/85289_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2020-07-27 | 1 | 1 | 1 | 2020-07-28 | 2020-07-27 | 1 | 2021-03-01 | View Edit Delete | ||||||||||||
| 729018 | 85288 | DASATINIB STADA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DASATINIB STADA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 50 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85288/85288_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85288/85288_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2020-07-27 | 1 | 1 | 1 | 2020-07-28 | 2020-07-27 | 1 | 2021-03-01 | View Edit Delete | ||||||||||||
| 729014 | 85286 | DOMEX 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | DOMEX 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 10 mg/20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85286/85286_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85286/85286_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2020-07-27 | 1 | 1 | 1 | 2020-07-28 | 2020-07-27 | 1 | 2023-07-24 | View Edit Delete | ||||||||||||
| 729013 | 85285 | DOMEX 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | DOMEX 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 10 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85285/85285_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85285/85285_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2020-07-27 | 1 | 1 | 1 | 2020-07-28 | 2020-07-27 | 1 | 2023-07-24 | View Edit Delete | ||||||||||||
| 729005 | 85282 | ZEKILEP 800 MG COMPRIMIDOS EFG | ZEKILEP 800 MG COMPRIMIDOS EFG, 30 comprimidos | 800 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85282/85282_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85282/85282_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-05-14 | View Edit Delete | ||||||||||||
| 729002 | 85279 | PREGABALINA CINFA 50 MG CAPSULAS DURAS EFG | PREGABALINA CINFA 50 MG CAPSULAS DURAS EFG, 56 cápsulas | 50 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85279/85279_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85279/85279_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2020-11-09 | View Edit Delete | ||||||||||||
| 729000 | 85277 | PREGABALINA CINFA 200 MG CAPSULAS DURAS EFG | PREGABALINA CINFA 200 MG CAPSULAS DURAS EFG, 84 cápsulas | 200 mg | 5 | 84 | 43 | 84 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85277/85277_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85277/85277_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2020-11-09 | View Edit Delete |
Page 180 of 1036, showing 20 records out of 20709 total, starting on record 3581, ending on 3600